Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition

Lione L, Salvatori E, Petrazzuolo A, Massacci A, Maggio R, Confroti A, Compagnone M, Aurisicchio L, Ciliberto G, Palombo F.
Oncoimmunology. 2021 Mar 23;10(1):1898832. doi: 10.1080/2162402X.2021.1898832. PMID: 33796408 Free PMC article.
Emerging data suggest that recognition of neoantigens for the generation of neoantigen cancer vaccines (NCVs) could have a key role in the activity of clinical immunotherapies. …This study aimed to understand the possible mechanisms of interaction be …